Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
August 2026 – November 2026 · 2 captures · latest observed messagingThe first and only FDA 510(k)-cleared autonomous AI that detects vision-threatening diabetic retinopathy.
EyeArt by Eyenuk is an autonomous, FDA-cleared AI for diabetic retinopathy screening and disease detection at the point of care.
26 August 2026 · The first and only FDA 510(k)-cleared autonomous AI that detects vision-threatening diabetic retinopathy.archived page
5 November 2026 · The first and only FDA 510(k)-cleared autonomous AI that detects vision-threatening diabetic retinopathy.current websiteHistorical capture not publicly available
Seen January 2025 · 1 captureHarnessing deep learning to prevent blindness
Harnessing deep learning to prevent blindness Learn how Eyenuk can help New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy June